Applied Genetic Technologies Corporation
AGTC · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $34 | $46 | $68 | $73 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $3 | $3 |
| Total Curr. Assets | $37 | $50 | $71 | $75 |
| Property Plant & Equip (Net) | $8 | $8 | $7 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $1 | $1 | $1 |
| Long-Term Investments | $0 | $8 | $8 | $0 |
| Tax Assets | $0 | $0 | -$1 | $0 |
| Other NC Assets | $11 | $0 | $2 | $8 |
| Total NC Assets | $20 | $17 | $17 | $17 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $57 | $67 | $87 | $92 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $4 | $2 |
| Short-Term Debt | $10 | $11 | $10 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $12 | $12 | $17 |
| Total Curr. Liab. | $27 | $25 | $26 | $24 |
| LT Debt | $11 | $12 | $14 | $17 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $0 | $0 | $0 |
| Total NC Liab. | $13 | $12 | $14 | $17 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $40 | $37 | $40 | $41 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$327 | -$308 | -$290 | -$276 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $344 | $338 | $337 | $327 |
| Total Equity | $18 | $29 | $47 | $51 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $57 | $67 | $87 | $92 |
| Net Debt | -$14 | -$24 | -$43 | -$51 |